Further analysis revealed that ASGR1 expression in CECs remains detectable in the early stages of HCC, such as in LC patients with lower Child-Pugh scores, suggesting its potential as a non-invasive tool for early tumor monitoring. This evidence concerns the gene ASGR1 and hepatocellular carcinoma.